![]() |
CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ |
| Journals - Article | |
|
|
|
| Česky / Czech version | Čs. Pediat., 57, 2002, No. 4, p. 172-173 |
|
Treatment of Life Threatening Haemorrhage in Infant with Haemangiomatosis and with Manifestations of the Kassabach-Merrit Syndrome by Activated Recombinant Factor VII (rFVIIa) Blatný J., Magnová O., Štěrba J. Oddělení dětské onkologie, FN Brno - Dětská nemocnice, primář MUDr. J. Štěrba, PhD. |
|
Summary: Recombinant Factor VIIa (rFVIIa) was successfully used to avert life-threatening bleeding in an infant with retroperitoneal haemangiomatosis and Kassabach-Merrit Syndrome. The use of rFVIIa in this patient was life-saving and enabled multimodal treatment of haemangiomatosis with chemotherapy and radiotherapy. This clinical experience thus contributes to the idea of further studies of rFVIIa as a haemostatic agent.
|
|
|
Order this issue
|
|
| BACK TO CONTENTS | ||
| | HOME PAGE | CODE PAGE | CZECH VERSION | |
| © 1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ |
| Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o. |
| WEBMASTER |